New Delhi: Dr Jitendra Singh, Union Minister of State (Independent Charge) for Science and Technology, Earth Sciences, MoS PMO, Personnel, Public Grievances & Pensions, Department of Atomic Energy and Department of Space, on Wednesday, informed the Lok Sabha that the Tata Memorial Centre (TMC) under the Department of Atomic Energy is spearheading a revolution in cancer treatment by expanding access to advanced, evidence-based therapies across India.
Dr Singh stated that the Tata Memorial Hospital has already established 11 hospitals in seven states, with eight functional centres in Mumbai, Varanasi, Vizag, Sangrur, Mullanpur, Guwahati, and Bhubaneswar, while three more are under construction. As a premier cancer centre, TMC not only delivers treatment but also provides national and international leadership in policy, education, and research on oncology.
Highlighting TMC’s achievements, Dr Singh noted several breakthroughs, including:
-
National Facility for Hadron Beam Therapy at ACTREC
-
India’s first homegrown CAR T-Cell therapy for cancer treatment
-
PREVALL, the first oral suspension of Mercaptopurine for Acute Lymphoblastic Leukemia
-
AKTOCYTE, a nutraceutical breakthrough poised to transform cancer care
-
TRANS-ARTERIAL Radioembolisation with indigenously sourced Y-90 Microspheres (BHABHASPHERES)
-
The largest Radiological Research Unit (Therapeutic Nuclear Medicine Unit) in the country
Dr Singh further underlined that TMC, through the National Cancer Grid (NCG), is working to make cutting-edge cancer therapies more accessible and affordable for the general public. The NCG currently connects 382 member organisations and is involved in treating around 8.5 lakh new cancer cases annually, creating what he described as a “massive and far-reaching impact” on cancer care delivery in India.
With its emphasis on evidence-based treatment, affordable innovation, and widespread collaboration, Dr Singh said TMC continues to stand at the forefront of India’s fight against cancer, ensuring that advanced therapies reach patients across all sections of society.
As far as Dewas and Shajapur constituencies is concerned, the people can utilize the facilities from the nearby following centres which are connected to NCG-TMC.
| Bansal Hospital | Cancer Unit, Bansal Hospital, Shahapura, Bhopal, Madhya Pradesh – 462016 |
| BIMR Oncology Centre | Surya Mandir Road, Near Sun Temple, Morar, Gwalior, Madhya Pradesh 474005 |
| Cancer Hospital & Research Centre (RCC) | Cancer Hill Gwalior 474 009, Madhya Pradesh |
| Career Institute of Medical Sciences and Cancer Research Institute | Career College Campus, opp. Dusherra Maidan, Govindpura, (BHEL), Bhopal – 462023 |
| Chirayu Medical College | Bhainsakhedi, Near Bairagarh, Bhopal Indore Highway, Bhopal, Madhya Pradesh 462030 |
| Indian Institute of Head & Neck Oncology | Cancer Foundation, Pigdambar Road, Rau, Near Indian Institute of Management, Indore, Madhya Pradesh 453331 |
| Padhar Hospital | P. O. Padhar, District Betul, Madhya Pradesh 460 005 |
| Priyamvada Birla Cancer Research Institute | M. P. Birla Hospital, J. R. Birla Road, Post Birla Vikas, Satna 485005, Madhya Pradesh |
| Shalby Hospital (Indore Division) | Part 5 & 6, Race Course Road, R S bhandari Marg, Janjeerwala Square, Indore-452003, Madhya Pradesh, India |
| Sri Aurobindo Institute of Medical Sciences | Indore – Ujjain State Highway, Near MR 10 Crossing, Indore, Madhya Pradesh 453555 |
| SRJ CBCC Cancer Center | 142, Phadnis Colony, A.B. Road, Near LIG Square, Indore, 452001 |
| Vidya Cancer Hospital | Old High Ct Rd, near High Court, MainaWali Gali, Dal Bazaar, Lashkar, Gwalior, Madhya Pradesh 474009 |
TMC will extend its network under hub and spoke model in a phased manner through technical collaboration and assistance, which will cover many more constituencies in the future.
Epidemiological surveys for health assessment in respect of employees working in close proximity to radiation and their families at each of the operating nuclear power plants in India have been carried out by reputed local medical colleges in association with Tata Memorial Centre (TMC), Mumbai, a premier cancer research centre in the country. In addition, annual medical checkups are carried out for occupational workers regularly. These studies/examinations have found that the morbidity pattern of all ailments is lower than the national average. There has also not been any rise in cancer morbidity, birth defects in the new born as compared to national average. All these studies and reports clearly establish that there are no adverse health impacts of the operation of the nuclear power plants on the people working in them.